Catalyst
Slingshot members are tracking this event:
Phase 3 data of Iomab-B in Hematopoietic Stem Cells Transplantation to be presented at TCT meeting February 24, 2019, 12:30pm CT.
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ATNM | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 25, 2019
Occurred Source:
https://ir.actiniumpharma.com/press-releases/detail/318/actiniums-late-breaking-oral-presentation-at-2019-tct
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Iomab-b, Hematopoietic Stem Cell Transplantation, Tct, Phase 3 Study
